Luong, Thien Vinh
Nielsen, Erik Nguyen
Falborg, Lise
Kjærulff, Mette Louise Gram
Tolbod, Lars Poulsen
Søndergaard, Esben
Møller, Niels
Munk, Ole Lajord
Gormsen, Lars Christian http://orcid.org/0000-0002-0144-1305
Clinical trials referenced in this document:
Documents that mention this clinical trial
Intravenous and oral whole body ketone dosimetry, biodistribution, metabolite correction and kinetics studied by (R)-[1-11C]β-hydroxybutyrate ([11C]OHB) PET in healthy humans
https://doi.org/10.1186/s41181-023-00198-z
Funding for this research was provided by:
Novo Nordisk Fonden (NNF18OC0052593)
Article History
Received: 19 April 2023
Accepted: 11 June 2023
First Online: 14 June 2023
Declarations
:
: We certify that the study was performed in accordance with the ethical stand- ards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. All participants were screened and signed an informed consent for participation and publication, before being included in the study. The study protocol was approved by The Central Denmark Region Committees on Health Research Ethics (no. 1-10-72-290-20) and the Danish Medicines Agency (2021-006866-19).
: The authors affirm that human research participants provided informed consent for publication of the images in Figs. InternalRef removed, InternalRef removed and InternalRef removed.
: The authors declare that they have no competing interests.